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Abstract
Background: In the last decades, there have been no studies carried out in Lithuania on the quality
of life of breast cancer patients. The aim of the present study was to evaluate changes in the quality
of life of Lithuanian women with the early stage of breast cancer nine months after surgery and its
dependence on surgical strategy, adjuvant chemotherapy and the social and demographic status of
the patients.
Methods:  Seventy-seven patients with early stage breast cancer filled in the FACT-An
questionnaire twice: one week and nine months after the surgery. The main age of the patients was
53.1 ± 10.6 years. We distinguished the mastectomy group and breast conserving treatment (BCT)
group with/without chemotherapy. The groups were identical in their social and demographic
status (age, education, occupation and marital status). Changes in the quality of life in these groups
were compared nine months after surgery.
Results: Nine months after surgery, the overall quality of life was found worse in both mastectomy
and BCT groups. Changes were induced by the worsening of the emotional and social well-being.
The quality of life became worse in the mastectomy plus chemotherapy sample. No changes were
detected in the mastectomy group without chemotherapy. In addition, the multivariate analysis
showed that the marital status was quite a significant determinant of the functional well-being.
Conclusion: Nine months after surgery, the study revealed a worsening of the overall quality of
life in both groups of patients – those who had undergone mastectomy and BCT. The quality of life
became considerably worse in the mastectomy plus chemotherapy group. Marital status was found
to exert the most considerable influence on the women's quality of life in comparison with other
social and demographic factors.
Background
Numerous studies on the quality of life of breast cancer
patients, carried out in the last decades, presented rather
scarce data on the psychosocial aspects of the transitional
period between the primary treatment and survival [1].
The first year is most stressful because of the adaptation to
the impact of the diagnosis, treatment and anxiety caused
by the follow-up visits and tests [2].
A review of the literature [3] has shown that the women's
psychological vulnerability and adaptation after mastec-
tomy and breast conserving treatment (BCT) differ insig-
nificantly, except the body image, which is better after
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BCT. A later 5-year prospective study [4] has shown that
although some quality of life domains became better after
BCT than after mastectomy, there was a direct relation to
the patients' age and other sociodemographic factors.
Studies have pointed out the importance of chemother-
apy for the quality of life after the surgical treatment of
breast cancer [1,5]. Chemotherapy in breast cancer 0-II
stages lowered the quality of life scores overall across the
four dimensions with a disproportionately greater impact
on women with lower level of education [5].
Nausea and vomiting are common side effects of adjuvant
chemotherapy. Additional troublesome effects are hair
loss, weight gain and concentration problems. A disrup-
tive effect of chemotherapy on younger women is prema-
ture menopause. One more distressing symptom that can
last particularly long after the treatment is fatigue [6]. The
Anemia Subscale of the Functional Assessment of Cancer
Therapy (FACT-An) is able to capture the physical and
psychological aspects of fatigue [7].
The aim of our study was to evaluate changes in the qual-
ity of life of Lithuanian women with the early stage of
breast cancer nine months following surgery and its
dependence on the surgical strategy, adjuvant chemother-
apy, social and demographic status.
Methods
This study is part of an extended prospective longitudinal
study on the early stage breast cancer patients. It was car-
ried out at the Department of Breast Surgery and Oncol-
ogy of the Institute of Oncology, Vilnius University in the
period between January 2004 and December 2005. 117
patients with T1-T2/N0-N1/M0 stages of breast cancer
were enrolled in the study. All women signed an informed
consent form approved by the Lithuanian Bioethics Com-
mittee. Data on the patients' diagnosis, treatment and age
were taken from the patients' records. The Functional
Assessment of Cancer Therapy General questionnaire
(FACT-G) along with the additional Anemia module
(FACT-An) was completed a week after surgery. On-treat-
ment assessment was necessary to compare the results [8].
The permission to use FACT-An for this study was received
from the authors. FACT-An was sent to the patients by
mail nine months later. Responses were received from 77
(66%) patients. The patients who did not send written
answers were contacted by phone to find out the reasons.
The most frequent explanation was: "because I felt bad" or
"I didn't understand some questions"; the other reasons
were: "at that time I was away" or "I didn't get the mail".
Only a few were traced to have changed their address or
phone number. Seventy-seven patients who completed
the questionnaires twice were included into the study.
The FACT-G is a 27-item compilation of general questions
divided into four primary QOL domains: Physical well-
being (PWB), Social/Family well-being (SWB), Emotional
well-being (EWB) and Functional well-being (FWB). Each
domain comprises six to seven questions scored by the use
of a Likert-type scale ranging from 0 (not at all) to 4 (very
much). The Total FACT-G score is obtained by summing
up four individual subscale scores (PWB, EWB, SWB and
FWB). The FACT-An includes 13 items that attempt to
identify the intensity of fatigue experienced during the 7-
day period before the questionnaire administration, plus
seven additional items (20 in total) pertaining to symp-
toms associated with anemic processes [7]. The Total
FACT-An score is a sum of four subscales plus the Anemia
subscale. The Trial Outcome Index (TOI) is a sum of PWB,
FWB and Anemia subscales. The TOI is an efficient sum-
mary index of physical/functional outcomes. All scales are
scored so that a higher score shows the better quality of
life.
The patients were divided into groups according to their
treatment and sociodemographic characteristics. Changes
in the quality of life in different groups nine months fol-
lowing surgery were compared.
The t-test for dependent samples was used to compare the
main score values for the QOL domains. The significance
was set at p < 0.05. Multivariate analysis was performed to
identify predictors for a poor QOL during the follow up.
The statistical program for FACIT scoring together with
SAS was used for data processing.
Results
The mean age of patients was 53.1 ± 10.6 years (range 32
– 78). The patients' distribution according to their treat-
ment and sociodemographic characteristics is presented
in Table 1.
Nine months after surgery, the overall quality of life (Total
FACT-G) scores and Total FACT-An scores showed a
decrease in both mastectomy and BCT groups (Table 2).
The social well-being (SWB) scores showed a decrease in
the mastectomy group, and the social well-being and
emotional well-being (EWB) scores became lower in the
BCT group.
In the groups of mastectomy with/without chemotherapy
and BCT with/without chemotherapy, QOL decreased
mostly in the mastectomy plus chemotherapy group
(SWB, EWB, FWB, Total FACT-G, Total FACT-An and TOI-
Anemia scores show decrease) (Table 2). In the mastec-
tomy group without chemotherapy, the QOL scores
remained the same as one week after surgery.BMC Public Health 2007, 7:124 http://www.biomedcentral.com/1471-2458/7/124
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In the BCT with chemotherapy group, SWB, EWB, Total
FACT-G and Total FACT-An scores showed a decrease. In
the group BCT without chemotherapy, only SWB scores
showed a significant decrease (Table 2).
In all the patients, the SWB, EWB, FACT-An, Total FACT-
G and Total FACT-An scores decreased significantly over
time (Table 2). These findings indicate a worsening of
QOL, as a result of the worsening in the emotional and
social well-being domains.
Multivariate regressive analysis shows the marital status to
be a significant determinant of changes in the functional
well-being domain of QOL (Table 3).
Table 2: FACT scores that significantly changed over time
One week after surgery (mean ± SD) 9 months after surgery (mean ± SD) p value
Total (n = 77)
SWB 21.5 ± 4.7 17.2 ± 5.9 0.000 000
EWB 17.5 ± 4.9 16.1 ± 5.3 0.0055
FACT-Anemia 61.4 ± 11.2 58.4 ± 13.9 0.019
Total FACT-G 79.2 ± 13.3 72.9 ± 16.9 0.0006
Total FACT-An 140.6 ± 22.2 131.4 ± 28.8 0.00099
Mastectomy (n = 30)
SWB 22.4 ± 4.5 17.5 ± 5.9 0.00018
Total FACT-G 80.5 ± 13.8 73.7 ± 16.7 0.033
Total FACT-An 143.2 ± 22.9 132.7 ± 28.5 0.041
BCT (n = 47)
SWB 21.0 ± 4.7 17.1 ± 6.0 0.000054
EWB 17.9 ± 4.8 15.7 ± 5.2 0.0017
Total FACT-G 78.3 ± 13.1 72.6 ± 17.2 0.007
Total FACT-An 138.9 ± 21.8 130.5 ± 29.2 0.01
Mastectomy with chemo (n = 16)
SWB 22.6 ± 4.5 16.4 ± 6.0 0.0004
EWB 18.9 ± 4.2 16.8 ± 5.1 0.059*
FWB 19.6 ± 4.1 15.5 ± 6.0 0.057*
Total FACT-G 85.1 ± 11.9 71.1 ± 16.2 0.005
Total FACT-An 150.9 ± 18.0 130.8 ± 27.5 0.012
TOI-Anemia 109.4 ± 133.3 97.6 ± 20.5 0.043
BCT with chemo (n = 26)
SWB 21.2 ± 5.7 16.3 ± 6.9 0.0015
EWB 17.6 ± 4.6 14.8 ± 5.3 0.0046
Total FACT-G 77.8 ± 15.1 69.9 ± 18.2 0.019
Total FACT-An 137.6 ± 24.7 127.1 ± 31.6 0.038
BCT without chemo (n = 21)
SWB 20.8 ± 3.4 17.9 ± 4.6 0.012
* Close to significant
Table 1: Clinical and demographic characteristics of patients
Variable Group N N (%)
Total Mastectomy 30 39
BCT 47 61
Mastectomy without chemo 14 18
with chemo 16 21
BCT without chemo 21 27
with chemo 26 34
Education College or less 38 49
University 39 51
Occupation Employed 51 66
Not employed 26 34
Marital status Married 43 56
Not married (unmarried, widowed or divorced) 34 44BMC Public Health 2007, 7:124 http://www.biomedcentral.com/1471-2458/7/124
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In the group of married women, the SWB, FACT-An, Total
FACT-G, Total FACT-An and TOI-Anemia scores showed a
significant decrease nine months after surgery (Figure 1).
In the group of unmarried women, only the SWB and
EWB scores significantly decreased over time. The
respondents' marital status had no significant influence
on their participation in the second interview.
Discussion
Some specific study limitations were the lack of data
about QOL of those who did not respond to the question-
naires. Besides, the patients answered the questionnaires
for the first time in the hospital and the second time at
home, and this might have influenced their answers. The
second limitation of the study was a small number of
patients, who were divided into four groups: mastectomy
with/without chemotherapy and BCT with/without
chemotherapy. This might have reduced the possibility of
generalizing the results.
The worsening was caused mostly by the lowered social
well-being scores in both groups and the lower emotional
well-being in the BCT group. No significant changes were
detected in the patients' physical well-being nine months
after surgery. Although some authors pointed out that the
social and emotional well-being shows no rapid or dra-
matical changes over time or in response to physical
health interventions [11], in our study the social and emo-
tional well-being subscales were rather sensitive to reflect
changes in the patients' quality of life after surgery and
chemotherapy.
One of the possible reasons for the QOL worsening the
social domain nine months after surgery might be the
changed role of the women in their family after the illness
or treatment. Their QOL was significantly influenced also
by the marital status, more than by any other social and
demographic variables including age, education and
occupation (Table 3). These data on the QOL of Lithua-
nian women with early stage breast cancer differed from
the findings of other researchers [4,5].
The declining quality of life in the BCT group in the emo-
tional and social domains confirmed the suggestion that
women treated with breast conservation often perceive
themselves as receiving less emotional support than those
who underwent mastectomy [3,6]. The high quality life in
the group of the mastectomy without chemotherapy
showed the high adaptation possibilities of these patients.
In our study, statistically significant (p < 0.05) changes in
QOL scores corresponded to the minimally important dif-
ferences (MID) for scores of selected FACT scales and sub-
scales [9-11]: 2 points for EWB [12,13], 2 – 3 points for
FWB [12], 3 – 7 points for Total FACT-G [12,14-16], 6
points for TOI-Anemia and 7 points for Total FACT-An
[14].
Conclusion
1. The overall quality of life declined nine months after
surgery in both groups of patients – those after mastec-
tomy and after BCT: social well-being worsened in the
mastectomy sample, while the social and emotional well-
being worsened in the BCT sample.
2. Nine months after surgery, the quality of life (SWB,
EWB, FWB, FACT-An TOI, Total FACT-G, Total FACT-An
and FACT-An scores) was the worst in mastectomy plus
chemotherapy group. No change in the quality of life was
FACT scores that changed significantly (*p < 0.05, **p <  0.01) over time for married (M) and not married (NM)  patients Figure 1
FACT scores that changed significantly (*p < 0.05, **p < 
0.01) over time for married (M) and not married (NM) 
patients.
Table 3: Results of multivariate regressive analysis (p values)
V a r i a b l e P W BS W BE W BF W B F A C T -
Anemia
Total FACT-
G
Total FACT-
An
TOI-Anemia
Age 0.95 0.98 0.3 0.69 0.76 0.65 0.88 0.95
Education 0.34 0.16 0.34 0.33 0.1 0.12 0.078 0.11
Occupation 0.91 0.14 0.52 0.11 0.19 0.77 0.68 0.85
Marital status 0.82 0.83 0.22 0.045* 0.19 0.73 0.40 0.15
* Statistically significantPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Public Health 2007, 7:124 http://www.biomedcentral.com/1471-2458/7/124
Page 5 of 5
(page number not for citation purposes)
found among the patients after mastectomy without
chemotherapy: nine months after surgery the quality of
life scores remained the same.
3. Marital status, more than the other social and demo-
graphic factors, has been found to influence changes in
the quality of life of Lithuanian women nine months after
surgery.
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